Abstract
In the present study, we investigated the in vitro effect of hypoxanthine, xanthine and uric acid, metabolites accumulating in tissue of patients with Lesch–Nyhan disease, on Na+, K+-ATPase activity in striatum of neonate rats. Results showed that all compounds significantly inhibited Na+, K+-ATPase activity. We also studied the kinetics of the inhibition of Na+, K+-ATPase activity caused by hypoxanthine. The apparent Km and Vmax of Na+, K+-ATPase activity for ATP as the substrate and hypoxanthine as the inhibitor were 0.97mM and 0.69nmol inorganic phosphate (Pi) released per min per mg of protein, respectively. Ki-value was 1.9μM, and the inhibition was of the non-competitive type. We also observed that the inhibitory effects of hypoxanthine, xanthine and uric acid probably occur through the same mechanism, suggesting a common binding site for these oxypurines on Na+, K+-ATPase. Therefore, it is conceivable that inhibition of brain Na+, K+-ATPase activity may be involved at least in part in the neuronal dysfunction characteristic of patients with Lesch–Nyhan disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Developmental Neuroscience
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.